Iowa City, IA - Friday, October 18, 2013

Friday, October 18, 2011


8:15 Diagnosis and Management of Severe Preeclampsia and HELLP Syndrome
- James N. Martin, Jr, MD, FACOG, FAGOS, FAHA
9:15 Controversies in the Treatment of Hypertension in Preeclampsia: Are We Missing the Boat?
- Thomas Easterling, MD
10:30 Angiogenesis and Biomarkers for Preeclampsia
- Ananth Karumanchi, MD
11:40 The Preeclampsia Registry: Banking our Stories to Accelerate Research
- Eleni Tsigas

 

1:00 Resident Research Presentations
Analysis of the Promoter Region of IDO
- Erica Hofland, MD
Changes in Flow Mediated Vasodilation in a Cohort at High Risk for Preeclampsia
- Joseph Kowalski, MD
Incidence of Persistent Granulation Tissue and Vaginal Bleeding following Vaginal Cuff Repair
- Amandeep Mahal, MD
Abortion & Contraception in Iowa: Factors affecting Contraception Choices
- Lindsey Michaels, MD
Toxicity of Weight-based Chemotherapy Dosing in Obese Patients
- Jean Hansen, DO
2:45 New 2013 ACOG Guidelines on Preeclampsia
- James N. Martin, Jr, MD, FACOG, FAGOS, FAHA
3:45 Biogenesis and Regulation of sFlt1, an Anti-Angiogenic Protein Implicated in Preeclampsia
- Christie Thomas, MD

Jointly Sponsored by: The Department of Obstetrics and Gynecology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, the NIH sponsored University of Iowa Women’s Reproductive Health Research Career Development Center, and the Preeclampsia Foundation

Program Brochure

Learners' Bill of Rights

Presenter Disclosures

Acknowledgment of Commercial Support